• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身抗体对血管紧张素 II 型 1 型受体信号转导和细胞增殖的分子作用。

Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation.

机构信息

Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, D-10178 Berlin, Germany.

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Nephrology and Medical Intensive Care, Campus Virchow Klinikum, D-13353 Berlin, Germany.

出版信息

Int J Mol Sci. 2022 Apr 2;23(7):3984. doi: 10.3390/ijms23073984.

DOI:10.3390/ijms23073984
PMID:35409344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8999261/
Abstract

The angiotensin II (Ang II) type 1 receptor (ATR) is involved in the regulation of blood pressure (through vasoconstriction) and water and ion homeostasis (mediated by interaction with the endogenous agonist). ATR can also be activated by auto-antibodies (ATR-Abs), which are associated with manifold diseases, such as obliterative vasculopathy, preeclampsia and systemic sclerosis. Knowledge of the molecular mechanisms related to ATR-Abs binding and associated signaling cascade (dys-)regulation remains fragmentary. The goal of this study was, therefore, to investigate details of the effects of ATR-Abs on G-protein signaling and subsequent cell proliferation, as well as the putative contribution of the three extracellular receptor loops (ELs) to Abs-ATR signaling. ATR-Abs induced nuclear factor of activated T-cells (NFAT) signaling, which reflects G and G activation. The impact on cell proliferation was tested in different cell systems, as well as activation-triggered receptor internalization. Blockwise alanine substitutions were designed to potentially investigate the role of ELs in ATR-Abs-mediated effects. First, we demonstrate that Ang II-mediated internalization of ATR is impeded by binding of ATR-Abs. Secondly, exclusive ATR-Abs-induced G activation is most significant for NFAT stimulation and mediates cell proliferation. Interestingly, our studies also reveal that ligand-independent, baseline ATR activation of G signaling has, in turn, a negative effect on cell proliferation. Indeed, inhibition of G basal activity potentiates proliferation triggered by ATR-Abs. Finally, although ATR containing EL1 and EL3 blockwise alanine mutations were not expressed on the human embryonic kidney293T (HEK293T) cell surface, we at least confirmed that parts of EL2 are involved in interactions between ATR and Abs. This current study thus provides extended insights into the molecular action of ATR-Abs and associated mechanisms of interrelated pathogenesis.

摘要

血管紧张素 II(Ang II)1 型受体(ATR)参与血压调节(通过血管收缩)和水和离子稳态(通过与内源性激动剂相互作用介导)。ATR 也可以被自身抗体(ATR-Abs)激活,这些抗体与多种疾病有关,如闭塞性血管病、先兆子痫和系统性硬化症。与 ATR-Abs 结合和相关信号级联(功能障碍)调节相关的分子机制的知识仍然是零散的。因此,本研究的目的是研究 ATR-Abs 对 G 蛋白信号转导和随后的细胞增殖的影响的细节,以及三个细胞外受体环(EL)对 Abs-ATR 信号转导的潜在贡献。ATR-Abs 诱导核因子活化 T 细胞(NFAT)信号转导,反映 G 和 G 的激活。在不同的细胞系统中测试了对细胞增殖的影响,以及激活触发的受体内化。设计了分块的丙氨酸取代,以潜在地研究 EL 在 ATR-Abs 介导的作用中的作用。首先,我们证明 ATR-Abs 的结合阻碍了 Ang II 介导的 ATR 内化。其次,ATR-Abs 诱导的 G 激活是 NFAT 刺激和介导细胞增殖的最重要因素。有趣的是,我们的研究还表明,配体非依赖性的、基线 ATR 对 G 信号转导的激活反过来对细胞增殖有负面影响。事实上,抑制 G 的基础活性增强了 ATR-Abs 触发的增殖。最后,尽管含有 EL1 和 EL3 的 ATR 分块的丙氨酸突变体不能在人胚肾 293T(HEK293T)细胞表面表达,但我们至少证实了 EL2 的部分参与了 ATR 和 Abs 之间的相互作用。因此,本研究为 ATR-Abs 的分子作用及其相关发病机制的相互关联机制提供了扩展的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d589/8999261/f3cb5a766074/ijms-23-03984-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d589/8999261/6aa85b09ccd5/ijms-23-03984-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d589/8999261/34bfdbc5bcbd/ijms-23-03984-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d589/8999261/29e4d39ee5bd/ijms-23-03984-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d589/8999261/0f9df5d2c744/ijms-23-03984-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d589/8999261/f3cb5a766074/ijms-23-03984-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d589/8999261/6aa85b09ccd5/ijms-23-03984-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d589/8999261/34bfdbc5bcbd/ijms-23-03984-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d589/8999261/29e4d39ee5bd/ijms-23-03984-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d589/8999261/0f9df5d2c744/ijms-23-03984-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d589/8999261/f3cb5a766074/ijms-23-03984-g005.jpg

相似文献

1
Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation.自身抗体对血管紧张素 II 型 1 型受体信号转导和细胞增殖的分子作用。
Int J Mol Sci. 2022 Apr 2;23(7):3984. doi: 10.3390/ijms23073984.
2
The angiotensin II type 1 receptor (AT1R) closely interacts with large conductance voltage- and Ca2+-activated K+ (BK) channels and inhibits their activity independent of G-protein activation.血管紧张素II 1型受体(AT1R)与大电导电压和Ca2+激活的钾离子(BK)通道密切相互作用,并独立于G蛋白激活抑制其活性。
J Biol Chem. 2014 Sep 12;289(37):25678-89. doi: 10.1074/jbc.M114.595603. Epub 2014 Jul 28.
3
Bivalent angiotensin II suppresses oxidative stress-induced hyper-responsiveness of angiotensin II receptor type I.二价血管紧张素 II 抑制氧化应激诱导的血管紧张素 II 受体 1 型超敏反应。
Eur J Med Chem. 2013 May;63:629-34. doi: 10.1016/j.ejmech.2013.02.041. Epub 2013 Mar 14.
4
Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting.血管紧张素和内皮素受体结构及其对信号调节和药物靶向的影响。
Front Endocrinol (Lausanne). 2022 Apr 19;13:880002. doi: 10.3389/fendo.2022.880002. eCollection 2022.
5
Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.膜拉伸对β-抑制蛋白偏向性血管紧张素II 1型受体信号传导的变构调节。
J Biol Chem. 2014 Oct 10;289(41):28271-83. doi: 10.1074/jbc.M114.585067. Epub 2014 Aug 28.
6
Interactions between AT1R and GRKs: the determinants for activation of signaling pathways involved in blood pressure regulation.血管紧张素受体 1(AT1R)与 G 蛋白偶联受体激酶(GRKs)之间的相互作用:参与血压调节的信号通路激活的决定因素。
Mol Biol Rep. 2023 Dec 29;51(1):46. doi: 10.1007/s11033-023-08995-0.
7
Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.发光生物测定法检测到的血管紧张素 II 型 1 受体功能性抗体与系统性硬化症的临床表现不相关:与 ELISA 检测到的血管受体和拓扑异构酶 I 抗体的比较。
Front Immunol. 2021 Dec 9;12:786039. doi: 10.3389/fimmu.2021.786039. eCollection 2021.
8
Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.血管紧张素 II 型 1 型受体变体改变内体受体-β-arrestin 复合物的稳定性和 MAPK 激活。
J Biol Chem. 2020 Sep 18;295(38):13169-13180. doi: 10.1074/jbc.RA120.014330. Epub 2020 Jul 23.
9
2-Methoxyestradiol causes matrix metalloproteinase 9-mediated transactivation of epidermal growth factor receptor and angiotensin type 1 receptor downregulation in rat aortic smooth muscle cells.2-甲氧基雌二醇引起基质金属蛋白酶 9 介导的血管紧张素受体 1 下调和表皮生长因子受体转激活在大鼠主动脉平滑肌细胞。
Am J Physiol Cell Physiol. 2018 May 1;314(5):C554-C568. doi: 10.1152/ajpcell.00152.2017. Epub 2018 Jan 24.
10
Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies.肾缺血和移植会导致血管收缩,这种收缩是由血管紧张素 II 型 1 受体激活抗体介导的。
Transplantation. 2012 Jul 15;94(1):8-13. doi: 10.1097/TP.0b013e3182529bb7.

引用本文的文献

1
Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α signaling.来自于肾移植血管病患者的自身抗体通过 GPCR 靶向 PAR1-TNF-α 信号转导,刺激内皮细胞和单核细胞中的促炎转换。
Front Immunol. 2023 Oct 30;14:1289744. doi: 10.3389/fimmu.2023.1289744. eCollection 2023.
2
Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism.扩充性血液透析通过 ERK/AP1/cFOS 依赖机制改善尿毒症诱导的血管保护因子 KLF2 损伤和内皮细胞的促炎预激。
Front Immunol. 2023 Sep 19;14:1209464. doi: 10.3389/fimmu.2023.1209464. eCollection 2023.
3

本文引用的文献

1
Autoantibodies Targeting AT- and ET-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription Factor.自身抗体靶向 AT 和 ET 受体通过 Ets-1 转录因子将血管内皮细胞增殖和凝血联系起来。
Int J Mol Sci. 2021 Dec 27;23(1):244. doi: 10.3390/ijms23010244.
2
Non-HLA antibodies targeting angiotensin II Type 1 receptor and endothelin-1 Type A receptors induce endothelial injury via β2-arrestin link to mTOR pathway.非 HLA 抗体靶向血管紧张素 II 型 1 受体和内皮素-1 型 A 受体通过β2- arrestin 连接到 mTOR 通路诱导内皮损伤。
Kidney Int. 2022 Mar;101(3):498-509. doi: 10.1016/j.kint.2021.09.029. Epub 2021 Oct 29.
3
Complement component C3 and C5b-9 deposition on hypoxia reperfused endothelial cells by non-HLA antibodies against RhoGDI2: A player involved in graft failure?补体成分 C3 和 C5b-9 在缺氧再灌注内皮细胞上的沉积由针对 RhoGDI2 的非 HLA 抗体引起:一个参与移植物失功的因素?
HLA. 2023 Feb;101(2):103-114. doi: 10.1111/tan.14858. Epub 2022 Nov 1.
Sirtuin1 contributes to the overexpression of Giα proteins and hyperproliferation of vascular smooth muscle cells from spontaneously hypertensive rats.
Sirtuin1 有助于自发性高血压大鼠血管平滑肌细胞中 Giα 蛋白的过度表达和过度增殖。
J Hypertens. 2022 Jan 1;40(1):117-127. doi: 10.1097/HJH.0000000000002985.
4
Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy.靶向 Gi/o 蛋白偶联受体信号通路可阻断 HER2 诱导的乳腺癌发生发展并增强 HER2 靶向治疗。
JCI Insight. 2021 Sep 22;6(18):e150532. doi: 10.1172/jci.insight.150532.
5
Angiotensin II-induced overexpression of sirtuin 1 contributes to enhanced expression of Giα proteins and hyperproliferation of vascular smooth muscle cells.血管紧张素 II 诱导的 SIRT1 过表达有助于 Giα 蛋白的高表达和血管平滑肌细胞的过度增殖。
Am J Physiol Heart Circ Physiol. 2021 Sep 1;321(3):H496-H508. doi: 10.1152/ajpheart.00898.2020. Epub 2021 Jul 16.
6
Prediction and primary prevention of major vascular complications in systemic sclerosis.系统性硬化症主要血管并发症的预测和一级预防。
Eur J Intern Med. 2021 May;87:51-58. doi: 10.1016/j.ejim.2021.01.022. Epub 2021 Feb 5.
7
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.对 SARS-CoV-2 生命周期、病理生理学的深入了解,以及针对 COVID-19 临床并发症的合理治疗方法。
J Biomed Sci. 2021 Jan 12;28(1):9. doi: 10.1186/s12929-020-00703-5.
8
Possible Therapeutic Interventions in COVID-19 Induced ARDS by Cotinine as an ACE-2 Promoter and AT-1R Blocker.烟碱作为 ACE-2 激动剂和 AT-1R 阻滞剂在 COVID-19 诱导的 ARDS 中的可能治疗干预。
Infect Disord Drug Targets. 2021;21(6):e170721189261. doi: 10.2174/1871526520666201218153554.
9
The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19.血管紧张素受体脑啡肽酶抑制剂在 COVID-19 多靶点治疗中的作用。
Int J Mol Sci. 2020 Nov 15;21(22):8612. doi: 10.3390/ijms21228612.
10
Location Bias as Emerging Paradigm in GPCR Biology and Drug Discovery.定位偏差作为GPCR生物学和药物发现中的新兴范式。
iScience. 2020 Oct 7;23(10):101643. doi: 10.1016/j.isci.2020.101643. eCollection 2020 Oct 23.